[1]
Yau H,Rivera K,Lomonaco R,Cusi K, The future of thiazolidinedione therapy in the management of type 2 diabetes mellitus. Current diabetes reports. 2013 Jun;
[PubMed PMID: 23625197]
[2]
Musso G,Cassader M,Paschetta E,Gambino R, Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis: A Meta-analysis. JAMA internal medicine. 2017 May 1;
[PubMed PMID: 28241279]
Level 1 (high-level) evidence
[3]
He L,Liu X,Wang L,Yang Z, Thiazolidinediones for nonalcoholic steatohepatitis: A meta-analysis of randomized clinical trials. Medicine. 2016 Oct;
[PubMed PMID: 27759627]
Level 1 (high-level) evidence
[4]
Yamanouchi T, Concomitant therapy with pioglitazone and insulin for the treatment of type 2 diabetes. Vascular health and risk management. 2010 Apr 15;
[PubMed PMID: 20407626]
[6]
Vieira R,Souto SB,Sánchez-López E,Machado AL,Severino P,Jose S,Santini A,Fortuna A,García ML,Silva AM,Souto EB, Sugar-Lowering Drugs for Type 2 Diabetes Mellitus and Metabolic Syndrome-Review of Classical and New Compounds: Part-I. Pharmaceuticals (Basel, Switzerland). 2019 Oct 10;
[PubMed PMID: 31658729]
[7]
Gor D,Gerber BS,Walton SM,Lee TA,Nutescu EA,Touchette DR, Antidiabetic drug use trends in patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease: A cross-sectional analysis of the National Health and Nutrition Examination Survey. Journal of diabetes. 2019 Oct 25;
[PubMed PMID: 31652390]
Level 2 (mid-level) evidence
[8]
Tyagi S,Gupta P,Saini AS,Kaushal C,Sharma S, The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases. Journal of advanced pharmaceutical technology
[PubMed PMID: 22247890]
[9]
Choi SS,Park J,Choi JH, Revisiting PPARγ as a target for the treatment of metabolic disorders. BMB reports. 2014 Nov;
[PubMed PMID: 25154720]
[10]
Floyd JS,Barbehenn E,Lurie P,Wolfe SM, Case series of liver failure associated with rosiglitazone and pioglitazone. Pharmacoepidemiology and drug safety. 2009 Dec;
[PubMed PMID: 19623674]
Level 2 (mid-level) evidence
[11]
DeFronzo RA, The effect of insulin on renal sodium metabolism. A review with clinical implications. Diabetologia. 1981 Sep;
[PubMed PMID: 7028550]
[12]
Juurlink DN,Gomes T,Lipscombe LL,Austin PC,Hux JE,Mamdani MM, Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study. BMJ (Clinical research ed.). 2009 Aug 18;
[PubMed PMID: 19690342]
[14]
Ali AA,Weinstein RS,Stewart SA,Parfitt AM,Manolagas SC,Jilka RL, Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation. Endocrinology. 2005 Mar;
[PubMed PMID: 15591153]
[15]
Dormuth CR,Carney G,Carleton B,Bassett K,Wright JM, Thiazolidinediones and fractures in men and women. Archives of internal medicine. 2009 Aug 10;
[PubMed PMID: 19667303]
[16]
Bilik D,McEwen LN,Brown MB,Pomeroy NE,Kim C,Asao K,Crosson JC,Duru OK,Ferrara A,Hsiao VC,Karter AJ,Lee PG,Marrero DG,Selby JV,Subramanian U,Herman WH, Thiazolidinediones and fractures: evidence from translating research into action for diabetes. The Journal of clinical endocrinology and metabolism. 2010 Oct;
[PubMed PMID: 20631021]
[17]
Meier C,Kraenzlin ME,Bodmer M,Jick SS,Jick H,Meier CR, Use of thiazolidinediones and fracture risk. Archives of internal medicine. 2008 Apr 28;
[PubMed PMID: 18443256]
[18]
Dormandy J,Bhattacharya M,van Troostenburg de Bruyn AR, Safety and tolerability of pioglitazone in high-risk patients with type 2 diabetes: an overview of data from PROactive. Drug safety. 2009;
[PubMed PMID: 19338377]
Level 3 (low-level) evidence
[21]
Lebovitz HE,Kreider M,Freed MI, Evaluation of liver function in type 2 diabetic patients during clinical trials: evidence that rosiglitazone does not cause hepatic dysfunction. Diabetes care. 2002 May;
[PubMed PMID: 11978674]
[22]
Idris I,Warren G,Donnelly R, Association between thiazolidinedione treatment and risk of macular edema among patients with type 2 diabetes. Archives of internal medicine. 2012 Jul 9;
[PubMed PMID: 22688528]
[23]
Fong DS,Contreras R, Glitazone use associated with diabetic macular edema. American journal of ophthalmology. 2009 Apr;
[PubMed PMID: 19181303]
[24]
Froment P,Touraine P, Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS). PPAR research. 2006;
[PubMed PMID: 17347533]
[26]
Kahn SE,Haffner SM,Heise MA,Herman WH,Holman RR,Jones NP,Kravitz BG,Lachin JM,O'Neill MC,Zinman B,Viberti G, Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. The New England journal of medicine. 2006 Dec 7;
[PubMed PMID: 17145742]